LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/CMS Finalizes Interoperability and Prior Authorization Rule
Legal & Regulatory and Reimbursement

CMS Finalizes Interoperability and Prior Authorization Rule

January 31, 2024 2 min read Premium comments

Advertisement

CMS Finalizes Interoperability and Prior Authorization Rule
Source: Shutterstock
#centersforMedicareandmedicaidservices#priorauthorizationSecondary

The Centers for Medicare & Medicaid Services (CMS) has published its CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F), reflecting its efforts to improve access to health information and the prior authorization process.

The final rule includes the following provisions: patient access API (application programming interfaces), provider access API, payer-to-payer API, and prior authorization API. The final rule does not apply to prior authorization decisions for drugs.

Under the final rule, impacted payers will be required to provide information about prior authorizations via the patient access API. Per the CMS Fact Sheet, impacted payers will be required to “implement and maintain a provider access API to share patient data with in-network providers with whom the patient has a treatment relationship.” This is meant to “facilitate care coordination and support movement toward value-based payment models.”

To facilitate care continuity, impacted payers will be required to implement and maintain a payer-to-payer API to make available certain data including information about certain prior authorizations. Beginning in 2027, impacted payers will also be required to, per the CMS Fact Sheet, “implement and maintain a prior authorization API that is populated with its list of covered items and services, can identify documentation requirements for prior authorization approval, and supports a prior authorization request and response.”

The final rule also includes a provision on improving prior authorization processes which includes the following: prior authorization decision timeframes; provider notice, including denial reason; and prior authorization metrics. The prior authorization policies have a compliance date starting January 1, 2026. Impacted payers will be required to provide prior authorization decision within 72 hours for urgent requests and 7 calendar days for non-urgent requests. In 2026, impacted payers will also have to provide a specific reason for any prior authorization denial decisions. Impacted payers, per the CMS Fact Sheet, will be required to “publicly report certain prior authorization metrics annually by posting them on their website.”

In the American Medical Association (AMA) press release, AMA President Jesse M. Ehrenfeld, M.D., MPH, expressed support for the reforms. Dr. Ehrenfeld commented, “The American Medical Association applauds Centers for Medicare & Medicaid Services Administrator Brooks-LaSure for heeding patients and the physician community in a final rule that makes important reforms in government-regulated health plans’ prior authorization programs for medical services.”

Dr. Ehrenfeld added, “Today’s final rule requires impacted plans to support an electronic prior authorization process that is embedded within physicians’ electronic health records, bringing much-needed automation and efficiency to the current time-consuming, manual workflow.”

Dr. Ehrenfeld continued, “The AMA also appreciates that the rule will significantly enhance transparency around prior authorization by requiring specific denial reasons and public reporting of program metrics as well as requiring that prior authorization information be available to patients to help them become more informed decision makers.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy